Tumor Biology

, Volume 32, Issue 1, pp 99–105 | Cite as

Downregulation of NDRG1 promotes invasion of human gastric cancer AGS cells through MMP-2

  • Yan-li Liu
  • Wen-tao Bai
  • Wen Luo
  • De-xin Zhang
  • Yan Yan
  • Zhi-kai Xu
  • Fang-lin Zhang
Research Article


The N-myc downstream-regulated gene-1 (NDRG1) has recently been proposed as a metastasis suppressor, but its precise role remains unclear. To investigate whether NDRG1 can indeed influence the metastasis progress, expression of endogenous NDRG1 was knocked down in human AGS gastric adenocarcinoma cells using RNA interference. Stable NDRG1 “silenced” transfectants showed similar growth rates as their control counterparts. By contrast, invasive ability in Matrigel invasion activity and Gelatinolytic activity by matrix metalloproteinase-2 (MMP-2) were markedly increased in NDRG1 “silenced” cells. Moreover, re-expression of NDRG1 by recombinant adenovirus Ad-NDRG1 in NDRG1 “silenced” cells inhibited the increased invasive ability. Further study, we found the induction of MMP-2 by downregulation of NDRG1 was mediated by MT1-MMP. Altogether, our results imply that NDRG-1 could play a key role in the regulation of cellular invasion and metastasis, which may involve the upregulation of matrix metalloproteinases.


NDRG1 MMP-2 MT1-MMP Invasion RNA interference Gastric cancer 



This study was supported by the grants NSFC (Natural Science Foundation of China) no. 30670100 and also partially supported by the grants Scientific Research Plan funded by Shaanxi Provincial Department of Education no.07JK371. The authors deeply thank Dr. Costa M (Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY) for providing the NDRG1 cDNA expression plasmid. We thank the anonymous reviewers for their insightful comments.


  1. 1.
    Arkenau HT. Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol. 2009;135:855–66.CrossRefPubMedGoogle Scholar
  2. 2.
    Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res. 2008;146:149–58.CrossRefPubMedGoogle Scholar
  3. 3.
    Iiizumi M, Liu W, Pai SK, Furuta E, Watabe K. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta. 2008;1786:87–104.PubMedGoogle Scholar
  4. 4.
    Kovacevic Z, Richardson DR. The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis. 2006;27:2355–66.CrossRefPubMedGoogle Scholar
  5. 5.
    Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA, Lee SW. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res. 1998;58:4439–44.PubMedGoogle Scholar
  6. 6.
    Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res. 2000;60:749–55.PubMedGoogle Scholar
  7. 7.
    Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene. 2004;23:5675–81.CrossRefPubMedGoogle Scholar
  8. 8.
    Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 2003;63:1731–6.PubMedGoogle Scholar
  9. 9.
    Agarwala KL, Kokame K, Kato H, Miyata T. Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem Biophys Res Commun. 2000;272:641–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M. Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells. Environ Health Perspect. 2002;110 Suppl 5:783–8.PubMedGoogle Scholar
  11. 11.
    Shin MH, Lee EG, Lee SH, Lee YS, Son H. Neural cell adhesion molecule (NCAM) promotes the differentiation of hippocampal precursor cells to a neuronal lineage, especially to a glutamatergic neural cell type. Exp Mol Med. 2002;34:401–10.PubMedGoogle Scholar
  12. 12.
    Stein S, Thomas EK, Herzog B, Westfall MD, Rocheleau JV, Jackson II RS, et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem. 2004;279:48930–40.CrossRefPubMedGoogle Scholar
  13. 13.
    Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M, et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res. 2006;66:6233–42.CrossRefPubMedGoogle Scholar
  14. 14.
    Bjorklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta. 2005;1755:37–69.PubMedGoogle Scholar
  15. 15.
    Noel A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol. 2008;19:52–60.CrossRefPubMedGoogle Scholar
  16. 16.
    Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994;370:61–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Inagaki Y, Tang W, Xu HL, Guo Q, Mafune K, Konishi T, et al. Localization of N-myc downstream-regulated gene 1 in gastric cancer tissue. Dig Liver Dis. 2009;41:96–103.CrossRefPubMedGoogle Scholar
  18. 18.
    Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis. 2009;26:19–34.CrossRefPubMedGoogle Scholar
  19. 19.
    Mori M, Mimori K, Shiraishi T, Fujie T, Baba K, Kusumoto H, et al. Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int J Cancer. 1997;74:316–21.CrossRefPubMedGoogle Scholar
  20. 20.
    Alakus H, Grass G, Hennecken JK, Bollschweiler E, Schulte C, Drebber U, et al. Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Histol Histopathol. 2008;23:917–23.PubMedGoogle Scholar
  21. 21.
    Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, Choi KM, et al. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res. 2006;66:4991–5.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2010

Authors and Affiliations

  1. 1.Department of MicrobiologyThe Fourth Military Medical UniversityXi’anPeople’s Republic of China
  2. 2.Department of Life ScienceXi’an University of Arts and ScienceXi’anChina

Personalised recommendations